Reassessment of Conservative Management for Stage T1N0M0 Transitional Cell Carcinoma of the Bladder
- 1 June 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (6) , 1907-1909
- https://doi.org/10.1016/s0022-5347(01)66043-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1994
- Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1992
- Urological Audit: the Role for an Aggressive Approach to High Grade Superficial Bladder TumoursBritish Journal of Urology, 1992
- Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year FollowupJournal of Urology, 1992
- Progression of Stage T1 Bladder Tumors After Intravesical Bacillus Calmette-GuerinJournal of Urology, 1991
- The Role of Radical Cystectomy in the Management of High Grade Superficial Bladder Cancer (PA, P1PIS and P2)Journal of Urology, 1990
- Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder CancerJournal of Urology, 1990
- Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycinUrology, 1990
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Stage T1, Grade 3 Transitional Cell Carcinoma of the Bladder: An Unfavorable Tumor?Journal of Urology, 1987